Home » Newsletters » BioWorld Science

BioWorld Science

Aug. 20, 2014

View Archived Issues

Alteration of endothelial gene methylation patterns underlies atherosclerotic damage

Preclinical data on novel anti-human CCR9 MAb for leukemia

Covance to conduct phase I/II study of AM-1030 in atopic dermatitis

Amgen reports results from second phase III trial of AMG-416 in SHPT

Novel missense mutation in AR gene responsible for CAIS symptoms

Novartis invests in Gamida Cell

Positive phase III results seen with ceftazidime-avibactam in intra-abdominal infections

Hyaluronidse-2 as potential new marker for platelet activation and IBD

MediciNova discloses results from phase IIa study of ibudilast in opioid dependence

Globavir aims to launch combination of approved drugs for Ebola virus infection during 2014

GlaxoSmithKline describes progress on HCV NS5A Inhibitors

New CETP inhibitors patented by Chong Kun Dang Holdings

Acetylon Pharmaceuticals patents novel HD3 inhibitors

U.S. and Japanese group disclose new FIXa inhibitors

Chinese researchers synthesize new ALK inhibitors

Amakem divulges novel ROCK inhibitors

Cannabis Technologies developing CTI-091 for arthritis and joint disease

Mount Tam Biotechnologies licenses lupus candidate from Buck Institute

Phylogica to provide drug discovery services to Genentech

Evotec to provide compound management for Medicines for MMV's drug discovery initiatives

Altor BioScience receives NCI grant to support bladder cancer trial

FDA approves IND for ViaCyte's stem cell therapy for type 1 diabetes

FDA approves Genzyme's eliglustat for Type 1 Gaucher disease

Clinigen Group acquires Ethyol from AstraZeneca

Boehringer Ingelheim files NDA for fixed-dose combination of tiotropium and olodaterol for COPD

Janssen launches tapentadol for cancer pain in Japan

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 8, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 8, 2025.
Mesothelin is biomarker, potential target in arthritic bone damage
BioWorld Science
In a recent study published in Cell Reports Medicine, researchers from the Institute of Chinese Materia Medica of the China Academy of Chinese Medical Sciences...
Epigenetic technology could eliminate misfolded prion proteins
BioWorld Science
The number of deaths caused by prion diseases reaches about 30,000 annually. Only 5 months pass from the diagnosis of seemingly healthy patients to the fatal...
CTAD 2025: Diagnosing semaglutide’s failure in Alzheimer’s trials
BioWorld
A little over a week after announcing that the Evoke and Evoke+ studies failed to show that oral semaglutide could slow cognition decline in patients with...